| VERV Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||
Below is a table of the VERV shares outstanding history going back to 6/16/2021:
Also see: VERV Market Cap History VERV YTD Return |
As of 5/7/2025 Verve Therapeutics has 89.14 million VERV shares outstanding. Investors often track the VERV shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows VERV share count trends over time, with 17 historical shares outstanding datapoints presented, dating back to 6/16/2021.

| VERV Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||
Below is a table of the VERV shares outstanding history going back to 6/16/2021:
Also see: VERV Market Cap History VERV YTD Return |
| VERV Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||
VERV Historical Shares Outstanding: +20.01% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||
| VERV Stock Price Chart |
| About Verve Therapeutics Inc |
| Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. Co. is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. Co.'s lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering low-density lipoprotein cholesterol (LDL-C), a root cause of atherosclerotic cardiovascular disease (ASCVD). VERVE-101 and VERVE-102 are designed to permanently turn off the PCSK9 gene in the liver and are being developed initially for heterozygous familial hypercholesterolemia (HeFH). We show 17 historical shares outstanding datapoints in our coverage of VERV's shares outstanding history. Understanding the changing numbers of VERV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VERV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VERV by allowing them to research VERV shares outstanding history as well as any other stock in our coverage universe. |
| VERV Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| VERV Share Performance |
| Shares Outstanding Peers |
| Verve Therapeutics (VERV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
VICL Shares Outstanding History VIE Shares Outstanding History VIGL Shares Outstanding History VINC Shares Outstanding History VIR Shares Outstanding History VIRI Shares Outstanding History VIRX Shares Outstanding History VIVE Shares Outstanding History VIVK Shares Outstanding History VIVO Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.